Name: Sionna Therapeutics, Inc. (SION) Financial Statements
Creator: FinSpry

Sionna Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Sionna Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.67	0.00	0.00
Gross Profit	-0.67	0.00	0.00
Operating Expenses
Research & Development	57.29	40.63	34.61
Selling, General & Administrative	13.27	9.71	6.77
Operating Expenses	70.56	50.33	41.37
Operating Income	-70.56	-50.33	-41.37
Other Income/Expense
Interest Income	8.17	2.77	1.13
Interest Expense	0.00	0.00	0.00
Other Income/Expense	0.70	0.30	0.00
Income
Income Before Tax	-61.69	-47.26	-40.24
Income Tax Expense	0.00	0.00	0.00
Net Income	-61.69	-47.26	-40.24
Net Income - Continuous Operations	-61.69	-47.26	-40.24
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-69.89	-49.75	-41.25
EBIT	-70.56	-50.33	-41.37
Depreciation & Amortization	0.67	0.58	0.12
Earnings Per Share
Basic EPS	-16.00	-16.00	-2.00
Diluted EPS	-16.00	-16.00	-2.00
Basic Shares Outstanding	3.86	2.93	17.33
Diluted Shares Outstanding	3.86	2.93	17.33